THERABIONIC INC.
THERABIONIC INC.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Not applicable | 2026-06-29 | NCT07672431 | |
| TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma | Hepatocellular Carcinoma Recurrent | Recruiting | Not applicable | 2026-04-13 | NCT07118202 | |
| Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer | Metastatic Colorectal Adenocarcinoma | Recruiting | Phase 2 | 2025-11-10 | NCT07130903 | |
| Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 | 2025-03-25 | NCT05776524 |